SRPT
Sarepta TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
SRPT vs peer average
52/100
SRPT vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · D 5 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Broad biopharma reference, not a direct Duchenne or gene-therapy operating peer; its much larger scale limits valuation comparability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SRPT
Sarepta Therapeutics
AMGN
Amgen
Grade
C
D
Momentum
44
94
Value
51
61
Sentiment
57
26
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs AMGN
SRPT / AMGN
Grade Position
In line
SRPT vs. peer average (C vs. C)
52/100
Momentum
44
AMGNValue
51
AMGNSentiment
57
SRPTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SRPT
AMGN is the first peer returned for this comparison set.